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Abstract  
In this paper we describe how a lightweight assessment method was developed to educate Irish 
software development organisations in relation to becoming medical device software suppliers.  
1. Introduction 
Research has identified two important sectors for the growth of the Irish economy they are Medical 
Devices and Information and Communications Technology (ICT). The Medical Device (MD) and 
diagnostic industry is a  cornerstone of the Irish economy. The sector has been identified, by both the 
Irish Industrial Development Authority and Enterprise Ireland, as a key growth area. Of the world’s top 
14 MD companies 11 have a base in Ireland; the indigenous base is also evolving rapidly; over 80% of 
the companies in this sector are involved in significant innovation.   
 
At present the Irish MD industry is focused on manufacturing. The sector is particularly dependent on 
the continued use of stents in the treatment of cardiovascular disease. Therefore, either the discovery of 
an effective drug treatment for vascular plague or the general migration of the manufacture of medical 
devices to low labour cost locations could negatively affect the future growth of the Irish MD sector. 
The Expert Group of Future Skills Needs (an Irish Government advisory body) [1], has highlighted ICT 
forms a major part of the MD sector globally, however in Ireland, where a significant ICT sector exists, 
only a small part of the MD sector involves ICT. The report also highlighted that Ireland does not have 
a strong presence in the production of electronic based medical devices (which would include 
substantial software development).  
 
There is therefore an opportunity to reduce the sectors dependence on stent manufacture by supporting 
the development of a software based MD industry in Ireland. This can be achieved through providing a 
range of services that will encourage existing indigenous MD companies to consider developing 
software and encourage multi-national MD companies to consider Ireland as a location for developing 
software. It will also provide opportunities for Irish software companies to develop software for the 
MD industry. However, to take up this opportunity they will need to demonstrate that their software 
development processes are both capable of producing high-quality software and achieving regulatory 
compliance.  Thus, there is a need for a low resource software process assessment to determine the 
current state of their software development practices.   
2. Software for the Medical Device Industry 
Due to the safety-critical nature of medical devices, organisations developing MD software are 
expected to produce high-quality software through the use of defined processes. To tackle these issues, 
governments have put in place regulatory bodies to define regulatory systems for medical devices and 
to ensure that only safe medical devices are placed on the market.  To aid the control of medical 
devices, regulatory bodies have adopted a classification scheme.  The device manufacturer is obliged to 
establish and perform both pre-market and post-market duties as defined in the quality system 
regulations.  The quality system requirements for Europe are defined in the ANSI/AAMI/ISO 13485 
standard [2] and the requirements for the U.S.A. are defined in the 21 CFR Part 820 Quality System 
Regulations [3]. Applicable requirements are typically directly related to the class of the device.   The 
regulatory or approved body, through its audits, checks conformance to the quality system 
requirements periodically.  
 
In an attempt to address the vagueness of the regulatory requirements, the FDA published separate 
regulatory guidance documents for required software activities [4,5,6].  In Europe, many organisations 
rely on the regulatory guidance documents from the FDA due to insufficient guidance provided for the 
equivalent CE marking process. Additionally, there has been a steady progression in the MD software 
sector with the release of new and updated standards in an attempt to address the knowledge gap that 
exists between the high-level regulatory requirements and the low level detail and knowledge required 
to adequately satisfy those requirements. 
   
Whenever we mention MD guidelines within this paper we refer to the following medical device 
standards and guidelines: ANSI/AAMI/IEC 62304 [7], FDA [4,5,6,8], European Council Guidelines 
[9], ISO 14971 [10], EN 60601-1-4 [11], GAMP 5 [12], TIR 32 [13], AAMI/IEC 61508 [14], and IEC 
60812 [15].  
3. Software Process for Medical Device Software Development 
With the development of formal SPI models such as CMMI® [16] and ISO/IEC 15504-5 [17] 
researchers within regulated environments such as the Space and Automotive industries started to 
investigate how they could utilise these models to improve the practices within their  industry domains. 
However, they discovered that although the existing models are comprehensive, neither CMMI® nor 
ISO/IEC 15504-5 addressed all of the regulatory needs and constraints of their specific industries.  
Researchers therefore sought to adopt the practices within these models while also expanding on them 
to account for regulatory requirements within their own domains.  This resulted in the production of 
full SPI models tailored specifically for the Space domain [18] and Automobile domain - Automotive 
SPICE [19].   
 
The authors are in the process of developing Medi SPICE which will be a comprehensive software 
process assessment model for the medical device industry [20] which is based on the AMMI/IEC 
62304 standard, associated MD standards and guidelines (listed at the end of section 2) and ISO/IEC 
15504-5. Medi SPICE like ISO/IEC 15504-5 and Automotive SPICE will contain both a Process 
Reference Model (PRM) and Process Assessment Model (PAM) that provide comprehensive coverage 
of the FDA and European Council guidelines, and associated standards (e.g. ISO 14971, IEC 60601-1-
4,TIR 32 and GAMP) for the complete software development lifecycle. The overall objective of Medi 
SPICE is to provide a conformity assessment scheme to support first, second or third party assessment 
results that may be recognised by the regulatory bodies. The Medi SPICE PRM and PAM is being 
released in phases and once complete, will consist of a defined set of software processes that will 
contain base practices which when utilised will assist medical device software development 
organisations to fulfil the regulatory guidelines and standards of the medical device industry.  
 
4. The Med-Adept Method  
One of the main goals of the Regulated Software Research Group in Dundalk Institute of Technology is 
to support the growth of a MD software development industry within Ireland. The authors previously 
developed the Adept method [21] which was based upon the ISO/IEC 15504-5 and CMMI® models. 
Consequently, we based the Med-Adept method upon relevant process areas from the CMMI® and 
ISO/IEC 15504-5 models and included input from AAMI/IEC 62304. This therefore enabled the 
existing Adept questions to be established as the foundation for the new method and for additional 
questions to be added to enable coverage of relevant AAMI/IEC 62304 process areas. The Med-Adept 
method consists of an assessment component for each process that is deemed applicable for software 
development organisations wishing to become medical device software developers. However, even 
though each assessment component adopts a CMMI process area name, it provides coverage of 
CMMI®, ISO/IEC 15504-5 and AAMI/IEC 62304 practices through containing questions that relate to 
CMMI®, ISO/IEC 15504-5 and AAMI/IEC 62304 
A key decision in the development of the Med-Adept method was to decide what process areas should 
be included. The process areas included in Med-Adept were chosen because:- 
A. They have process area counterparts included within the  AAMI/IEC 62304 standard; 
B. They were previously included in the Adept method; 
We then analysed each of the CMMI® process areas using the factors in Table 1 (see below). 
 
Table 1. Suitability of CMMI
®
 process areas for inclusion in Med-Adept method 
 
CMMI
®
 Process Area Satisfies A Satisfies  
B 
Requirements Management Yes Yes 
Project Planning Yes Yes 
Project Monitoring & Control Yes Yes 
Configuration Management Yes Yes 
Measurement & Analysis  Yes 
Process & Product QA Yes Yes 
Supplier Agreement Management   
Requirements Development Yes Yes 
Technical Solution Yes Yes 
Verification Yes Yes 
Product Integration Yes Yes 
Validation Yes Yes 
Organisational Process Focus   
Organisational Training   
Organisational Process Definition & 
IPPD 
  
Integrated Project Management & IPPD Yes  
Risk Management Yes Yes 
Decision Analysis & Resolution Yes  
Organisational Process Performance    
Quantitative Project Management   
Organisational Innovation & Deployment   
Causal Analysis & Resolution Yes  
 
Table 1, illustrates, that eleven of the twenty-two process areas from the CMMI® model satisfied both 
factors and should be included in Med-Adept. 
  
4.1 What processes are included in Med-Adept?  
In addition to the Med-Adept method enabling assessment against eleven CMMI® process areas it 
should also assess ISO/IEC 15504-5 and AAMI/IEC 62304 processes that are related to the eleven 
selected CMMI® process areas. The procedure for selecting the Med-Adept process areas was as 
follows:- 
Step 1. Select one of the eleven CMMI® process areas (previously included in Adept – satisfies B in 
table 1); 
Step 2. Serially scan this process area against the following list of 16  AAMI/IEC 62304 processes and 
select related ISO/IEC 15504-5 processes:- Risk Management, Configuration Management, Software 
Requirements Analysis, Software Development Planning, Software Architectural Design, Software 
Detailed Design, Software Integration, Software Unit Implementation and Verification, Integration 
Testing, Software System Testing, Quality Assurance, Software Release, Software Maintenance, 
Software Problem Resolution, Documentation, Software Safety Classification. 
Step 3. Repeat Steps 1 and 2 for each of the eleven CMMI® process areas. 
As a result of performing these steps the CMMI® to AAMI/IEC 62304 and ISO/IEC 15504-5 processes 
(software related) area linkages were determined (see table 2) and the Med-Adept method provides 
coverage of 11 CMMI
®
 process areas, 12 ISO/IEC 15504-5 and 11 AAMI/IEC 62304 processes.  
Table 2. CMMI
®
 to AAMI/IEC 62304 and ISO/IEC 15504-5 process linkages 
Med- Adept Processes 
Adept Processes  
Selected CMMI Process 
Area 
Selected ISO/IEC 
15504-5 Process 
AAMI/EC 62304 Process 
Risk Management Risk Management Risk Management  
Configuration Management Configuration Management Configuration Management 
Requirements Management 
 
Requirements Development 
Requirements Elicitation 
Software Requirements 
Analysis  
Software Requirements Analysis 
Project Planning 
 
Project Monitoring & Control 
Project Management Software Development Planning 
 
Technical Solution 
 
Software Design 
Software Construction 
Software Architectural Design  
Software Detailed Design 
Product Integration Software Integration  Software Integration 
Validation 
 
Verification  
Software Testing 
Verification 
Validation 
Software Unit Implementation 
and Verification 
Integration Testing 
Software System Testing 
Process and Product Quality 
Assurance 
Quality Management System Quality Assurance 
  
 
Software Release 
Software Maintenance  
 
Software Problem Resolution 
Documentation 
Software Safety Classification 
It can also be observed that Med-Adept does not provide coverage of 5 AAMI/IEC 62304 processes. 
However, the main purpose of Med-Adept is to provide a low overhead assessment that will educate 
organisations in relation to generic SPI and in particular medical device software development process. 
Therefore, it is not intended to provide comprehensive coverage of CMMI, AAMI/IEC 62304 and 
ISO/IEC 15504-5 processes, but rather a starting point through focusing upon the processes that will 
provide the most benefit to organisations. 
To encourage uptake of the Med-Adept assessment by Irish software organisations we wish to reduce 
the cost and time associated with the assessment.  On-site interviewing is restricted to one day as this 
proved attractive to companies in relation to performing the Adept assessment [22]. Consequently, an 
Med-Adept assessment method will be limited to providing coverage of four selected CMMI® and (the 
related) AAMI/IEC 62304 and ISO/IEC 15504-5 processes as the aim of Medi-Adept is to introduce 
organisations to medical device software processes in a low overhead manner. Companies wishing to 
be assessed in more than 4 of these processes will then be able to extend the assessment across 
additional days. 
 
4.2 The Stages of the Med-Adept Method 
The Med-Adept method is divided into eight stages and the assessment team consists of two assessors 
who conduct the assessment between them.  
Stage 1 (Develop Assessment Schedule and Receive Site Briefing) involves a preliminary meeting 
between the assessment team and the software company.  The assessment team will discuss the main 
drivers for the company embarking upon a Med-Adept assessment During stage 2 (Conduct Overview 
Briefing) the lead assessor provides an overview of the Med-Adept method for members of the 
organisation who will be involved in subsequent stages. Stage 3 (Analyse Key Documents) provides a 
brief insight into project documentation. The primary source of data for the Med-Adept method is 
through a series of process area interviews conducted during stage 4. The main part of the Med-Adept 
method is stage 4. In this stage key staff members from the assessed organisation are interviewed. In an 
attempt to reduce the overhead of the assessment we restrict the scope of the assessment to 4 process 
areas (there are a maximum of 4 interviews). Each interview is scheduled to last approximately 1.5 
hours. Each interview involves two assessors, and at least one representative from the company is 
present for each process area interview. 
Table 3, illustrates (for example, the processes of risk management and configuration management) 
that the process interviews within an Med-Adept assessment includes additional questions to provide 
coverage of relevant AAMI/IEC 62304 and ISO/IEC 15504-5 processes in addition to the CMMI 
process areas. When developing the interview questions we mainly looked at the base practices and did 
not perform a detailed investigation into similarities and differences between CMMI®, AAMI/IEC 
62304 and ISO/IEC 15504-5.  Instead we checked the relevant interview questions from the Adept 
method to see if they covered their counterpart in AAMI/IEC 62304 and ISO/IEC 15504-5 processes. 
Table 3. Breakdown of Med-Adept Questions 
AHAA Interviews No. of Adept Questions No. of New Questions No. of Med-Adept 
Questions 
Risk Management 
39 23 62 
Configuration Management 
39 2 41 
 
 
Within Adept 39 questions were used to provide coverage of the specific goals of the CMMI® and the 
base practices of ISO/IEC 15504-5 for risk management. Med-Adept is more comprehensive and has 
62 scripted questions for risk management (see Table 3). Med-Adept not only contains CMMI and 
ISO/IEC 15504-5 based questions, but also 23 additional questions that are specifically related to the 
risk management process of AMMI/IEC 62304 and other associated medical device standards and 
regulations. The configuration management process has 2 additional questions added to meet  the 
specific requirements of Med-Adept. 
On completion of a Med-Adept assessment companies will receive feedback regarding the current state 
of their practices in relation to CMMI, AAMI/IEC 62304 and ISO/IEC 15504-5 (unless a company 
specifies that they are only interested in one of the models). 
Stage 5 (Generate Assessment Results and Create the Findings Report) is a collaborative exercise 
between the assessors which results in the development of the findings report. The resultant findings 
report consists of a list of strengths, issues and suggested actions for each of the process areas 
evaluated. The findings report is developed through reviewing the interview notes for each of the 4 
assessed process areas. Stage 6 (Deliver the findings report) involves presenting the findings report to 
the staff in the assessed organisation who participated in the interviews. Stage 7 (Develop a SPI Path 
with the Company) involves collaborating with staff from the assessed company to develop a roadmap 
that will provide guidance to the company in relation to practices that will offer the greatest benefits in 
terms of the organisation’s business goals. Companies wishing to become medical device software 
developers will be recommended to focus upon establishing working practices that will assist them to 
adhere to AAMI/IEC 62304 practices and to prepare them for future Medi SPICE assessments. Stage 8 
(Re-assess the SPI Path and Produce a Final Report) involves revisiting the assessed company 
approximately 3 months after the completion of stage 7 and reviewing progress against the SPI path 
that was developed in stage 7. The outcome of this stage will be an updated SPI path and a final report 
detailing the progress that has been accomplished along with additional recommendations. This stage is 
important as it provides feedback and assistance to the assessed company after a period of time. This 
stage also assists in compiling research material in terms of SPI experiences.  
5. Observations from a Med-Adept assessment 
The Med-Adept assessment was performed in an Irish MD organisation MedSoft (a pseudonym). 
MedSoft were aware of CMMI and ISO/IEC 15504-5, but they had not previously utilized these 
process improvement models. Before undertaking the assessment they were not familiar with the 
AAMI/IEC 62304 MD standard. On completion of the assessment the software development manager 
stated it had been beneficial to MedSoft in a number of ways. These included the provision of high-
level training in relation to CMMI and ISO/IEC 15504-5 in the areas of risk management and 
configuration management. In addition they gained an insight into the MD regulations that are required 
to achieve compliance for these specific practices. Another important outcome was the assessment 
provided an introduction to the MD software development standard AAMI/IEC 62304. MedSoft also 
recognised the benefits of having an external auditor and in this situation receiving guidance in relation 
to improving their configuration management and risk management processes. Furthermore MedSoft 
identified the benefits of utilizing the Med-Adept lightweight assessment which did not require 
preparation on their part and took very little time to perform. 
The results from the Med-Adept assessment highlighted that MedSoft’s configuration management 
processes were very strong with regard to control, but they could be improved in terms of management.  
It also identified there was room for improvement in their risk management development practices. 
Therefore, if the recommendations in the Med-Adept findings report were implemented they would 
enable MedSoft to have both strong configuration and risk management practices.  
The software development manager and the engineer both agreed that the strengths and weaknesses 
highlighted in the report were an accurate reflection of the company’s risk management and 
configuration management practices. The management and staff of MedSoft also recognized that the 
recommendations were realistic and achievable and if implemented they would bring improvements 
and benefits to their organization. The software development manager stated that initially he intended 
championing these improvements in the location where the assessment took place. He then went on to 
state that he would oversee their implementation in other locations so that the overall organization 
could benefit from the assessment.  MedSoft representatives met internally to discuss developing a SPI 
path after the Med-Adept findings report was presented.  The objective of this meeting was to review 
and prioritise the report’s recommendations and to plan how they will be implemented in a new project 
(which is stage 7 of Med-Adept).  
Having discussed the assessment process with the management of MedSoft they outlined the benefits it 
offered. They also requested that within 6 months their software processes would be re-assessed (which 
is stage 8 of Med-Adept). With the objective of receiving feedback regarding the progress of their SPI 
initiative. This will also provide the assessment team with an opportunity to validate and or refine their 
improvement recommendations. Regarding Med-Adept the only area for improvement they identified 
was only 2 process areas had been assessed. It was agreed that on the release of the second edition of 
Med-Adept an additional assessment involving other software process areas will be undertaken. 
6. Conclusions and Future Plans 
The goal of a Med-Adept assessment is not certification but to provide a lightweight method for 
indicating to companies: the current state of their software processes; recommendations as to how they 
might improve; the status of their software processes both in terms of CMMI® and AAMI/IEC 62304 
and ISO/IEC 15504-5; and their suitability to become medical device software developers. It is 
important to educate software development organisations in relation to how they may become medical 
device software developers and how they should improve their software development processes so that 
they may compete within this domain. This requires an appropriate approach that facilitates education 
and engages software development managers in a quality agenda. The application of the Med-Adept 
method will help raise the level of SPI knowledge within the assessed organisations. Also, the high-
level findings report and the detailed SPI path will provide a road map for SPI within each assessed 
organisation.  Furthermore, as the Med-Adept method requires little internal staff time, this should 
prove attractive to SMEs from a resource viewpoint.  
From a research perspective the Med-Adept method: enables the Regulated Software Research Group 
(RSRG) at Dundalk Institute of Technology to gain an understanding as to whether existing software 
development practices within Irish companies are more CMMI, AAMI/IEC 62304 or ISO/IEC 15504-5 
based. This will assists the RSRG in understanding areas that will present Irish software development 
companies with difficulties if they are to become medical device software development organisations – 
therefore this awareness will enable the RSRG to provide guidance within these areas; and will enable 
the RSRG to gain an understanding in relation to the strengths (profile) that Irish software companies 
possess particularly in relation to developing software for the medical device industry. 
This paper has described the development of the Med-Adept method that provides coverage of 11 
CMMI process areas, 12 ISO/IEC 15504-5 and 11 AAMI/IEC 62304 processes. It described a pilot 
release of the Med-Adept method, providing coverage of 2 processes. It also considered how a Med-
Adept assessment was conducted in an Irish medical device software company. The company has since 
prioritised actions and are currently engaged in adopting a number of the recommendations as part of 
their software development practices.  In the future we plan to extend the number of processes that may 
be assessed. We will extend the Med-Adept assessment to provide coverage of the remaining nine 
applicable processes that are displayed in table 1.  
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